89 related articles for article (PubMed ID: 15488648)
1. "Constitutive" skin pigmentation: a marker of breast cancer risk?
Manning JT; Caswell N
Med Hypotheses; 2004; 63(5):787-9. PubMed ID: 15488648
[TBL] [Abstract][Full Text] [Related]
2. The potential clinical applications of insulin-like growth factor-1 ligand in human breast cancer.
Chong YM; Subramanian A; Sharma AK; Mokbel K
Anticancer Res; 2007; 27(3B):1617-24. PubMed ID: 17595785
[TBL] [Abstract][Full Text] [Related]
3. A pilot study to establish a clinical model to perform phase II studies of breast cancer chemopreventive agents in women at high risk with biomarkers as surrogate endpoints for activity.
Stearns V; Gallagher A; Kleer CG; Singh B; Freedman M; Haddad BR; Isaacs C; Warren R; Brown M; Cullen J; Trock B; Hayes DF
Clin Cancer Res; 2004 Dec; 10(24):8332-40. PubMed ID: 15623610
[TBL] [Abstract][Full Text] [Related]
4. Differences in breast cancer risk factors by tumor marker subtypes among premenopausal Vietnamese and Chinese women.
Nichols HB; Trentham-Dietz A; Love RR; Hampton JM; Hoang Anh PT; Allred DC; Mohsin SK; Newcomb PA
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):41-7. PubMed ID: 15668474
[TBL] [Abstract][Full Text] [Related]
5. Human pigmentation variation: evolution, genetic basis, and implications for public health.
Parra EJ
Am J Phys Anthropol; 2007; Suppl 45():85-105. PubMed ID: 18046745
[TBL] [Abstract][Full Text] [Related]
6. MRI and mammography surveillance of women at increased risk for breast cancer: recommendations using an evidence-based approach.
Granader EJ; Dwamena B; Carlos RC
Acad Radiol; 2008 Dec; 15(12):1590-5. PubMed ID: 19000876
[TBL] [Abstract][Full Text] [Related]
7. Predicting risk of breast cancer in postmenopausal women by hormone receptor status.
Chlebowski RT; Anderson GL; Lane DS; Aragaki AK; Rohan T; Yasmeen S; Sarto G; Rosenberg CA; Hubbell FA;
J Natl Cancer Inst; 2007 Nov; 99(22):1695-705. PubMed ID: 18000216
[TBL] [Abstract][Full Text] [Related]
8. Cyclin E as a prognostic and predictive marker in breast cancer.
Hunt KK; Keyomarsi K
Semin Cancer Biol; 2005 Aug; 15(4):319-26. PubMed ID: 16043362
[TBL] [Abstract][Full Text] [Related]
9. Prenatal and perinatal correlates of adult mammographic breast density.
Cerhan JR; Sellers TA; Janney CA; Pankratz VS; Brandt KR; Vachon CM
Cancer Epidemiol Biomarkers Prev; 2005 Jun; 14(6):1502-8. PubMed ID: 15941963
[TBL] [Abstract][Full Text] [Related]
10. Apocrine sweat gland obstruction by antiperspirants allowing transdermal absorption of cutaneous generated hormones and pheromones as a link to the observed incidence rates of breast and prostate cancer in the 20th century.
McGrath KG
Med Hypotheses; 2009 Jun; 72(6):665-74. PubMed ID: 19307063
[TBL] [Abstract][Full Text] [Related]
11. Role of MRI in screening women at high risk for breast cancer.
Lehman CD
J Magn Reson Imaging; 2006 Nov; 24(5):964-70. PubMed ID: 17036340
[TBL] [Abstract][Full Text] [Related]
12. Bone turnover markers as predictors of skeletal complications in prostate cancer, lung cancer, and other solid tumors.
Brown JE; Cook RJ; Major P; Lipton A; Saad F; Smith M; Lee KA; Zheng M; Hei YJ; Coleman RE
J Natl Cancer Inst; 2005 Jan; 97(1):59-69. PubMed ID: 15632381
[TBL] [Abstract][Full Text] [Related]
13. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
[TBL] [Abstract][Full Text] [Related]
14. In situ levels of oestrogen producing enzymes and its prognostic significance in postmenopausal breast cancer patients.
Licznerska BE; Wegman PP; Nordenskjöld B; Wingren S
Breast Cancer Res Treat; 2008 Nov; 112(1):15-23. PubMed ID: 18030614
[TBL] [Abstract][Full Text] [Related]
15. Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics.
Ellis MJ; Tao Y; Luo J; A'Hern R; Evans DB; Bhatnagar AS; Chaudri Ross HA; von Kameke A; Miller WR; Smith I; Eiermann W; Dowsett M
J Natl Cancer Inst; 2008 Oct; 100(19):1380-8. PubMed ID: 18812550
[TBL] [Abstract][Full Text] [Related]
16. Presence of epithelial cells in nipple aspirate fluid is associated with subsequent breast cancer: a 25-year prospective study.
Buehring GC; Letscher A; McGirr KM; Khandhar S; Che LH; Nguyen CT; Hackett AJ
Breast Cancer Res Treat; 2006 Jul; 98(1):63-70. PubMed ID: 16685591
[TBL] [Abstract][Full Text] [Related]
17. Risk assessment: controversies and management of moderate- to high-risk individuals.
Brown P
Breast J; 2005; 11 Suppl 1():S11-9. PubMed ID: 15725110
[TBL] [Abstract][Full Text] [Related]
18. Androgen therapy for loss of desire in women: is the benefit worth the breast cancer risk?
Schover LR
Fertil Steril; 2008 Jul; 90(1):129-40. PubMed ID: 18023435
[TBL] [Abstract][Full Text] [Related]
19. Hazards for pain severity and pain interference with daily living, with exploration of brief pain inventory cutpoints, among women with metastatic breast cancer.
Castel LD; Abernethy AP; Li Y; Depuy V; Saville BR; Hartmann KE
J Pain Symptom Manage; 2007 Oct; 34(4):380-92. PubMed ID: 17583467
[TBL] [Abstract][Full Text] [Related]
20. Analysis of population characteristics related to the total effective xenoestrogen burden: a biomarker of xenoestrogen exposure in breast cancer.
Fernandez MF; Santa-Marina L; Ibarluzea JM; Exposito J; Aurrekoetxea JJ; Torne P; Laguna J; Rueda AI; Pedraza V; Olea N
Eur J Cancer; 2007 May; 43(8):1290-9. PubMed ID: 17466515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
